For any queries or concerns regarding this formulation or its use, please do not hesitate to contact us
No peer-reviewed clinical studies, pharmacokinetic interaction data, or regulatory guidance exist on the combined use of AOD 9604 and retatrutide
Injection site pain, redness or swelling may occur (local inflammation)
CJ Pabla, physician and owner of Integrative Medicine, Laser and Aesthetics
Does the Delivery Method Matter
Needle Subcutaneous (subQ) Short insulin needle, 1/2 inch Intramuscular (IM) Longer needle, deeper insertion Ease of self-injection Subcutaneous (subQ) Simple, pinch and inject Intramuscular (IM) Harder to place safely alone Soreness and bruising Subcutaneous (subQ) Usually minimal Intramuscular (IM) More common What PeRx ships for Subcutaneous (subQ) This is the intended route Intramuscular (IM) Not the prescribed route Unless your provider specifically instructs otherwise, inject BPC-157 subcutaneously with the insulin syringes included in your order